Fresenius Medical Care AG & Co. KGaA(DE:FME)
€40.81+0.09 (+0.22%)
DE:FME
Fresenius Medical Care AG & Co. KGaA financials statements
€40.81
At close:+0.09 (+0.22%)
Want to see DE:FME full AI Analyst Report?
Fresenius Medical Care AG & Co. KGaA (FME) Ratios
23 Followers
Fresenius Medical Care AG & Co. KGaA Ratios
DE:FME's free cash flow for Q3 2026 was €559.59M. For the 2026 fiscal year, DE:FME's free cash flow was decreased by €-237.97M and operating cash flow was €797.56M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.26 | 1.40 | 1.42 | 1.27 | 1.10 |
| Quick Ratio | 0.92 | 1.03 | 1.07 | 0.91 | 0.82 |
| Cash Ratio | 0.26 | 0.20 | 0.23 | 0.20 | 0.20 |
| Solvency Ratio | 0.15 | 0.13 | 0.11 | 0.12 | 0.13 |
| Operating Cash Flow Ratio | 0.43 | 0.42 | 0.43 | 0.34 | 0.34 |
| Short-Term Operating Cash Flow Coverage | 1.66 | 4.13 | 2.78 | 1.59 | 1.29 |
| Net Current Asset Value | € -8.82B | € -9.88B | € -10.40B | € -12.10B | € -12.42B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.33 | 0.36 | 0.37 | 0.39 |
| Debt-to-Equity Ratio | 0.81 | 0.75 | 0.88 | 0.86 | 0.95 |
| Debt-to-Capital Ratio | 0.45 | 0.43 | 0.47 | 0.46 | 0.49 |
| Long-Term Debt-to-Capital Ratio | 0.30 | 0.30 | 0.34 | 0.32 | 0.32 |
| Financial Leverage Ratio | 2.33 | 2.30 | 2.49 | 2.31 | 2.46 |
| Debt Service Coverage Ratio | 1.51 | 2.94 | 1.92 | 1.68 | 1.35 |
| Interest Coverage Ratio | 4.74 | 3.42 | 3.22 | 4.27 | 0.85 |
| Debt to Market Cap | 0.62 | 0.53 | 0.71 | 0.95 | 0.51 |
| Interest Debt Per Share | 38.40 | 38.81 | 42.52 | 46.28 | 46.67 |
| Net Debt to EBITDA | 2.76 | 3.07 | 3.63 | 3.71 | 3.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.62% | 24.60% | 25.32% | 27.37% | 28.82% |
| EBIT Margin | 9.66% | 7.57% | 6.79% | 8.14% | 10.40% |
| EBITDA Margin | 17.01% | 16.58% | 15.08% | 16.60% | 19.39% |
| Operating Profit Margin | 9.31% | 7.20% | 7.04% | 7.93% | 1.71% |
| Pretax Profit Margin | 7.70% | 5.47% | 5.31% | 6.29% | 8.92% |
| Net Profit Margin | 4.98% | 2.78% | 2.57% | 3.47% | 5.50% |
| Continuous Operations Profit Margin | 6.07% | 3.83% | 3.14% | 4.61% | 6.92% |
| Net Income Per EBT | 64.68% | 50.89% | 48.30% | 55.23% | 61.66% |
| EBT Per EBIT | 82.77% | 75.91% | 75.43% | 79.28% | 521.70% |
| Return on Assets (ROA) | 3.15% | 1.60% | 1.47% | 1.88% | 2.82% |
| Return on Equity (ROE) | 7.35% | 3.69% | 3.66% | 4.36% | 6.93% |
| Return on Capital Employed (ROCE) | 7.38% | 4.99% | 4.92% | 5.25% | 1.11% |
| Return on Invested Capital (ROIC) | 5.34% | 3.35% | 3.30% | 3.60% | 0.79% |
| Return on Tangible Assets | 6.05% | 3.16% | 2.78% | 3.65% | 5.23% |
| Earnings Yield | 8.24% | 4.15% | 4.48% | 7.51% | 5.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.25 | 4.93 | 4.79 | 5.21 | 4.92 |
| Payables Turnover | 19.78 | 14.81 | 19.06 | 15.24 | 14.63 |
| Inventory Turnover | 6.82 | 7.05 | 6.67 | 6.32 | 6.15 |
| Fixed Asset Turnover | 3.02 | 2.66 | 2.61 | 4.63 | 4.08 |
| Asset Turnover | 0.63 | 0.58 | 0.57 | 0.54 | 0.51 |
| Working Capital Turnover Ratio | 10.03 | 7.97 | 8.99 | 15.87 | 19.32 |
| Cash Conversion Cycle | 93.51 | 101.14 | 111.79 | 103.83 | 108.53 |
| Days of Sales Outstanding | 58.43 | 74.01 | 76.19 | 69.99 | 74.17 |
| Days of Inventory Outstanding | 53.53 | 51.77 | 54.75 | 57.78 | 59.31 |
| Days of Payables Outstanding | 18.45 | 24.64 | 19.15 | 23.95 | 24.96 |
| Operating Cycle | 111.96 | 125.79 | 130.94 | 127.78 | 133.48 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 9.21 | 8.13 | 8.96 | 7.39 | 8.50 |
| Free Cash Flow Per Share | 6.06 | 5.75 | 6.63 | 4.92 | 5.58 |
| Dividend Paid and CapEx Coverage Ratio | 2.00 | 2.28 | 2.59 | 1.94 | 2.00 |
| Capital Expenditure Coverage Ratio | 2.93 | 3.41 | 3.84 | 2.99 | 2.91 |
| Operating Cash Flow Coverage Ratio | 0.25 | 0.22 | 0.22 | 0.16 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.12 | 0.14 | 0.11 | 0.14 |
| Free Cash Flow Yield | 14.88% | 13.02% | 17.46% | 16.10% | 9.77% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.13 | 24.13 | 22.32 | 13.31 | 17.27 |
| Price-to-Sales (P/S) Ratio | 0.60 | 0.67 | 0.57 | 0.46 | 0.95 |
| Price-to-Book (P/B) Ratio | 0.89 | 0.89 | 0.82 | 0.58 | 1.20 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.72 | 7.68 | 5.73 | 6.21 | 10.24 |
| Price-to-Operating Cash Flow Ratio | 4.43 | 5.43 | 4.24 | 4.14 | 6.72 |
| Price-to-Earnings Growth (PEG) Ratio | 0.15 | 3.16 | -0.86 | -0.44 | -1.05 |
| Enterprise Value Multiple | 6.31 | 7.11 | 7.43 | 6.49 | 8.36 |
| Enterprise Value | 21.07B | 22.79B | 21.78B | 20.90B | 28.58B |
| EV to EBITDA | 6.31 | 7.11 | 7.43 | 6.49 | 8.36 |
| EV to Sales | 1.07 | 1.18 | 1.12 | 1.08 | 1.62 |
| EV to Free Cash Flow | 11.93 | 13.51 | 11.21 | 14.48 | 17.48 |
| EV to Operating Cash Flow | 7.86 | 9.55 | 8.29 | 9.64 | 11.48 |
| Tangible Book Value Per Share | -1.86 | -2.63 | -4.04 | -6.35 | -6.29 |
| Shareholders’ Equity Per Share | 45.71 | 49.68 | 46.42 | 52.68 | 47.72 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.30 | 0.29 | 0.27 | 0.22 |
| Revenue Per Share | 67.41 | 65.90 | 66.30 | 66.15 | 60.14 |
| Net Income Per Share | 3.36 | 1.83 | 1.70 | 2.30 | 3.31 |
| Tax Burden | 0.65 | 0.51 | 0.48 | 0.55 | 0.62 |
| Interest Burden | 0.80 | 0.72 | 0.78 | 0.77 | 0.86 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.15 | 0.16 | 0.12 | 0.12 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Income Quality | 2.74 | 3.22 | 3.59 | 3.22 | 2.57 |
Currency in EUR
